Skip to main content
. Author manuscript; available in PMC: 2014 Aug 20.
Published in final edited form as: Arch Intern Med. 2010 Sep 13;170(16):1490–1498. doi: 10.1001/archinternmed.2010.309

Table 2.

Summary of presentations given at NCI and NIDDK* meetings regarding presence of erythropoietin receptors, erythropoietin-induced changes in signaling, erythropoietin-induced -induced changes in cellular function, qualitative conclusions and descriptions of conflicts of interest are summarized.

Presenter Report Detection of EpoR Report Erythropoietin-Induced Signaling Events Report Erythropoietin-Induced Harmful Cellular Function Changes Presenter Affiliation Participation at NIDDK or NCI Meeting* Number of Papers Included in Review Co- Authored by Presenter**
Presenters with Academic Affiliations (n= 12)
Acs, G Yes Not Investigated Yes University of Pennsylvania NCI 10
Arcasoy, MO Yes Yes Yes Duke University NIDDK, NCI 6
Blau, CA Yes Not Investigated Yes University of Washington NIDDK 0
Gewirtz, D Not Investigated No No Virginia Commonwealth University NCI 0
Hardee, ME Not Investigated Yes Yes Memorial Sloan-Kettering Cancer Center NCI 3
Henke, M Yes Not Investigated Yes University of Freiburg NCI 0
Jeong, JY Yes Not Investigated Yes Harvard University NIDDK 2
Lai, SY Yes Yes Yes University of Pittsburgh NCI 2
Lappin, TRJ Not Investigated Yes Yes Queen’s University Belfast NIDDK 3
Lodish, HF Yes Yes Not Investigated Massachusetts Institute of Technology NIDDK 1
Sytkowski, AJ Yes Yes Yes Harvard University NIDDK 3
Xu, X Yes Yes Yes University of Pennsylvania NIDDK, NCI 4
Presenters with ESA Manufacturer Affiliation (n= 4)
Begley, CG No No No AMGEN NIDDK, NCI 1
Elliot, S No No No AMGEN NIDDK 2
Farrell, FX Yes No No Centocor NCI 2
Sinclair, AM No Not Investigated No AMGEN NIDDK 2
*

NIDDK refers to the Workshop on Erythropoietin Receptor (Epo-R) Expression and Function in Non-Hematopoietic Tissues hosted by the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, MD (Sep 8–9, 2008). NCI refers to Erythropoietic Stimulating Agents and Tumor Growth Workshop hosted by National Cancer Institute in Rockville, MD (Dec 18–19, 2007).

**

Based on the 74 articles on EpoRs included in Table 1A.